Compare · LSTA vs SHC
LSTA vs SHC
Side-by-side comparison of Lisata Therapeutics Inc. (LSTA) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LSTA and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $4.44B, about 153.7x LSTA ($28.9M).
- Over the past year, LSTA is up 31.6% and SHC is up 38.5% - SHC leads by 6.9 points.
- SHC has been more active in the news (4 items in the past 4 weeks vs 2 for LSTA).
- SHC has more recent analyst coverage (25 ratings vs 0 for LSTA).
- Company
- Lisata Therapeutics Inc.
- Sotera Health Company
- Price
- $3.21-3.89%
- $15.59+1.63%
- Market cap
- $28.9M
- $4.44B
- 1M return
- -36.12%
- +13.80%
- 1Y return
- +31.56%
- +38.45%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 2
- 4
- Recent ratings
- 0
- 25
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest LSTA
- SEC Form SC14D9C filed by Lisata Therapeutics Inc.
- SEC Form 8-K filed by Lisata Therapeutics Inc.
- Lisata Therapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits
- SEC Form SC14D9C filed by Lisata Therapeutics Inc.
- SEC Form 10-K filed by Lisata Therapeutics Inc.
- SEC Form SC14D9C filed by Lisata Therapeutics Inc.
- Lisata Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure
- Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
- SEC Form SC14D9C filed by Lisata Therapeutics Inc.
- Lisata Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
Latest SHC
- Sotera Health Announces First-Quarter 2026 Earnings Release Date
- SEC Form DEFA14A filed by Sotera Health Company
- SEC Form DEF 14A filed by Sotera Health Company
- SEC Form 3 filed by new insider Ostrowski Erika
- SEC Form 4 filed by Dimitrief Alexander
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- SEC Form 3 filed by new insider Krause Kenneth D.
- Sotera Health Company filed SEC Form 8-K: Leadership Update
- Sotera Health Appoints Kenneth D. Krause to the Board of Directors
- Director Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)